Top Section
Explore Business Standard
Don’t miss the latest developments in business and finance.
Book Building - SME
₹ -
₹ -
-
₹ -
NSE - SME
-
-
-
Initial public issue of upto 53,18,000 equity shares of face value of Rs. 10/- each (Equity Shares) of Vardaan Biotech Limited (VBL or the Company) at an issue price of Rs. [*] per equity share (including a share premium of Rs. [*] per equity share) for cash, aggregating up to Rs. [*] crores (Public Issue) comprising a fresh issue of upto 48,18,000 equity shares aggregating to Rs. [*] crores (the Fresh Issue) and an offer for sale of upto 5,00,000 equity shares by Lokendra Singh Rajput; (The Selling Shareholders) aggregating to [*] equity shares by the selling shareholders (Offer for Sale) aggregating to Rs. [*] crores out of which 5,32,000 equity shares of face value of Rs. 10/- each, at an issue price of Rs. [*] per equity share for cash, aggregating Rs. [*] crores will be reserved for subscription by the market maker to the issue (the Market Maker Reservation Portion). The public isssue less market maker reservation portion i.e. issue of [*] equity shares of face value of Rs. 10/- each, at an issue price of Rs. [*] per equity share for cash, aggregating up to Rs. [*] crores is hereinafter referred to as the Net Issue. The public isssue and net issue will constitute [*]% and [*]% respectively of the post-issue paid-up equity share capital of the company. The price band and the minimum bid lot will be decided by the company.
To Meet the Working Capital Requirements. General Corporate Purpose.
Vardaan Biotech Ltd, 9 ShivShakti Indl Es, J R Boricha Marg, Lower Parel, Mumbai - 400 011
Phone - 91-22-23010771/23018261
Fax - 91-22-23012517
Email - investorgrievance@vardaanbiotech.com
Website - www.vardaanbiotech.com